CpG-oligodeoxynucleotide (ODN), a synthetic analog of bacteria DNA, has attracted attention because it activates cells of an adaptive immune system and the innate immune system. In this study, we investigated whether CpG-ODN has radioprotective effects, when administered after total-body irradiation (TBI). Mice were treated with 50 μg CpG-ODN via intraperitoneal injection (i.p) within 30 min, 24 h and 48 h after TBI. Our results showed that the survival rate was enhanced at various levels of TBI. The calculated dose reduction factor (DRF) was 1.2. Bone marrow cell count and bone marrow histological examination indicated that CpG-ODN minimized the bone marrow damage induced by TBI. The data of the white blood cell (WBC) count, exogenous (CFU-S) and endogenous (endoCFU-S) colony forming unitspleen count demonstrated that CpG-ODN reduced primitive hematopoietic stem cells damage and reconstituted hematopoiesis after TBI. Thus, we suggested that CpG-ODN had the potential to contribute to the improvement of the survival rate and limitation of myelosuppression induced by TBI.
INTRODUCTION
A number of bacterial constituents have been shown to stimulate host defense, among them, the best studied examples are bacterial lysate, 1) lipopolysaccharide (LPS) 2) and flagellin.
3) It is recognized that some of these agents protected against damage induced by radiation. 1) CpG-oligodeoxynucleotide (ODN), a synthetic analog of bacteria DNA, 4) was proved to repress immune cells apoptosis induced by radiation. 4) Since radiation produces harmful effects on living animals by inducing cell death, we will initiate investigation of potential radioprotective effects on the whole animal. It is known that one of the most vulnerable tissues to the harmful effects of total-body irradiation (TBI) is hematopoiesis. Tim Sparwasser et al previous study showed that CpG-ODN caused extramedullary murine hematopoiesis after TBI. 6) But no information is available regarding to its potential contribution to mediate protective effects on bone marrow hematopoiesis after TBI. Therefore, the objective of the current study is to determine that CpG-ODN also have protective effects on the bone marrow hematopoiesis after TBI.
MATERIALS AND METHODS

Reagent
CpG-oligodeoxynucleotide (ODN) was synthesized in Shanghai Sangon Biological Engineering Technology Services Co. Ltd. (Sangon, China). CpG-ODN sequence used in this study was CpG-ODN 2395. The sequences were 5'-TCG TCG TTT TCG GCG CGC CG-3' (regular letters represent PS linkage and italic letters represent CpG-ODN dinucleotides). 7) The compound was diluted with PBS to concentration of 250 μg/ml and stored at 4°C.
Radiation and administration
Mice were placed in specially designed, well-ventilated acrylic container and subjected to TBI. The dose rate was approximately 0.8 Gy/min. Radiation was delivered by the 60 Co source (Radiation facility, the Second Military Medical University, Shanghai, China). Mice were administered 50 μg CpG-ODN within 30 min after TBI via intraperitoneal injection (i.p) and continued administered at 24 h and 48 h after TBI.
Determination of acute toxicity
The acute toxicity of CpG-ODN was determined by administration of various doses (450, 900, 1350 μg per mice) of CpG-ODN. Mortality of mice (n = 8 mice/group) was observed up to 14 days after agent treatment.
Survival and dose reduction factor (DRF) analysis
Mice (n = 16-20 mice/group) were administered CpG-ODN after exposure to TBI with 6.0, 6.5 8.0 and 10.0 Gy. We monitored daily for 30 days, to determine survival rates. The moribund mice in this experiment were sacrificed by cervical dislocation. On day 31, all the surviving mice were euthanized by cervical dislocation too. The data was reported as the percentage of animals surviving. The protective capacity of CpG-ODN was expressed as DRF. DRF was calculated by dividing the LD50/30 of the radiated and administrated CpG-ODN group and by LD50/30of the radiation alone group.
8)
White blood cell (WBC) count
The peripheral blood was collected from tail vain (n = 6 mice/group) at 1 d (initial phase), 9 d (critical phase) and 28 d (recovery phase) after 6.0 Gy of TBI and the erythrocyte was eliminated with 3% acetic acid. WBC was determined by using of the cell counter analyser system (CASY, Innovatis, Germany).
Live bone morrow cells count
The femurs (n = 12 femurs /group) were removed from anesthetized mice on 1 d, 9 d and 28 d after 6.0 Gy of TBI and bone marrow cells were flush with PBS. The number of live bone marrow cell per femur was determined by using CASY.
Bone morrow histological examination
The femurs were removed from anesthetized mice on 1 d, 9 d and 28 d after 6.0 Gy of TBI, which were fixed in 4% paraformaldehyde in PBS, treated with a formic acid-sodium citrate decalcification solution for 5 days, embedded in paraffin, and stained with Hematoxylin and Eosin (H&E).
Exogenous (CFU-S) and Endogenous (endoCFU-S) colony forming unit-spleen assay
CFU-S formation was assayed by the method of Till and
McCulloch (1961), 9) which was carried out to measure the survival of primitive hematopoietic stem cells. Briefly, Groups of mice (n = 4 mice/group) were exposed to 6.0 Gy alone or were treated with CpG-ODN after 6.0 Gy of TBI. The femurs were aseptically removed from anesthetized mice and were flushed with RPMI1640 supplemented with 10% fetal bovine serum, using 25-gauge needle. The bone marrow cell suspensions were diluted to 5 × 10 4 /mL, which were injected into the caudal vein of each mice (n = 12 mice/ group), which had been exposed to 7.0 Gy of TBI 2-3 h earlier. The number of macroscopic colonies per spleen was determined 9 days later.
EndoCFU-S formation was also assayed by the method of Till and McCulloch (1961) . 9) Briefly, mice (n = 8 mice/ group) were exposed to 6.5 Gy of TBI. They were killed by cervical dislocation on 10 days after TBI and their spleens were removed and fixed in Bouin's solution. The number of macroscopic colonies per spleen was determined.
Statistical analysis
The values given in figures were represented mean ± SD and analyzed by SPSS13.0 software. The LD50/30 values and the DRF were determined by regression analysis. T test was used to detect differences between the radiation alone group and the radiation and administration CpG-ODN group. p < 0.05 was considered as statistically significant and p < 0.01 was considered high statistically significant.
RESULTS AND DISCUSSION
Determination of acute toxicity
The administration of different doses (450, 900, 1350 μg per mice) of CpG-ODN did not induce adverse effects on the body weights and general health of the animals or mortality during 14 days observation period. In the following experiment, it was not possible to administer higher dose. Therefore, it was concluded that CpG-ODN was safe and did not any adverse effects.
Survival, LD 50/30 and DRF analysis
To investigate whether CpG-ODN has radioprotective activity, Mice were treated with 50 μg CpG-ODN via intraperitoneal injection (i.p) within 30 min, 24 h and 48 h after TBI The experiment data showed that the irradiated alone mice displayed survival rates of 95%, 58%, 35% and 0% when irradiated with 6.0, 6.5 8.0 and 10.0 Gy, respectively. Administration with CpG-ODN after at various doses of TBI enhanced the survival rates, yielding rates of 100%, 89%, 81% and 25% at 6.0, 6.5, 8.0 and 10.0 Gy, respectively (Fig.  1A) . Regression analysis of the radiation survival data produced LD50/30 values of 9.0 for the radiation and administration CpG-ODN group and 7.6 for the radiation alone group (Fig. 1B) . The calculated DRF was 1.2. These results indicated that CpG-ODN administrated after TBI enhanced the survival of mice.
Effect of CpG-ODN on WBC
TBI significantly lowered WBC in irradiated animals.
10) It was generally agreed that radiation death in the sublethal dose range was due to impairment of bone marrow hematopoietic function and that reduction of WBC which ultimately predisposed to infection. Accordingly, we used peripheral blood WBC count as indicators of bone marrow hematopoietic function. The data showed that administration of CpG-ODN significantly increased the number of WBC on 1 d, 9 d and 28 d after TBI (Fig. 2) . This result appeared that CpG-ODN administered after TBI prevented WBC death and minimized hematopoiesis damage induced by TBI.
Effect of CpG-ODN on bone marrow cell
Hematopoietic tissue was very sensitive to radiation. One of the major syndromes of damage induced by TBI is myelosuppression.
2) We used bone marrow cell count and bone morrow histological examination as indicators of radiationinduced myelosuppression. As shown in Fig. 3A , on 1 day after TBI, both the radiation and administration CpG-ODN group and the radiation alone group showed almost similar number of bone morrow cells. But on 9 d and 28 d, the num- ber of bone marrow cell in the radiation and administration CpG-ODN group was significantly higher than the number of bone marrow cells in the radiation alone group.
Histological examination of bone marrow preparation also showed greater cells in the radiation and administration CpG-ODN group than the radiation alone group. The data was supported by bone morrow cells count (Fig. 3B) . These results indicated that CpG-ODN minimized radiationinduced myelosuppression.
Exogenous (CFU-S) and Endogenous (endoCFU-S) colony forming unit-spleen count
CFU-S and endoCFU-S were capable of lodging in the spleen and forming macroscopic nodules at some days after adoptive transfer in the bone marrow-ablated host, which exhibited many characteristics of primitive hematopoietic stem cells, such as extensive proliferative capacity, the ability for self-renewal, and the capability of generating multiple hematopoietic lineages that rescued animals from radiation damage. 6) As shown in Fig. 4A , We observed that the number of CFU-S per femur was 2.1 fold greater the radiation and administration CpG-ODN group than the radiation alone group. Moreover, a significantly enhanced number of endoCFUA-S also was detected in spleen taken from radiated and administered CpG-ODN mice (Fig. 4B) . Thus, these results suggested that CpG-ODN stimulated the generation, redistribution and mobilization of primitive stem cell and reconstitute hematopoiesis after TBI.
After TBI, the bone marrow is the major site of injury, because of contained rapid proliferating cell populations. 2) Hematopoietic depression and subsequent susceptibility to potentially lethal opportunistic infections are welldocumented phenomena following radiation exposure. 6) In this study, we observe that CpG-ODN administered after TBI enhanced the survival of mice. Bone marrow cell count and bone morrow histological examination as indicator of bone marrow damage showed that the damage was immunized. There is general consensus that WBC count, CFU-S and endoCFU-S are the good indication of bone marrow cell viability and/or the stimulation, proliferation and survival of cells in mice recovering from exposure to TBI.
11) Taken together, our results suggest that CpG-ODN administered after TBI has a significant contribution to reduce the hematopoiesis damage induced by TBI.
Although the effect of CpG-ODN on hematopoiesis is not fully understood in irradiated animals, one possible mechanism of action is that CpG-ODN stimulates immune cell to secrete cytokines. Published data suggested that bacterial stimuli, especially LPS, 2) could trigger hematopoiesis possibly via macrophage-derived hematopoietic growth factors, including interleukin(IL)-1, granulocyte-macrophage colonystimulating factor (GM-CSF), IL-6, IL-11, IL-12, interferon (IFN)-α 7) and tumor necrosis factor (TNF)-α, which stimulated the generation and mobilization of the blood cells, and reestablished homeostasis after injury to combat bacterial infections. [12] [13] [14] [15] [16] [17] [18] The biological responses trigger immune cells by CpG-ODN display remarkable parallels to LPS. Given the LPS-like activity of CpG-ODN, we anticipate that CpG-ODN and LPS share operationally similar characteristics, such as mobilization and increased production of hematopoietic cells.
2) Furthermore, the previous data have showed that oxidative stress was reduced by anti-inflammatory. Some reporters have demonstrated that CpG-ODN activated B cells and stimulated APCs such as dendritic cells and macrophages to secrete these anti-inflammatory and exhibited high serum concentrations in vivo. 7, 13, 19) We speculate that CpG-ODN also reduce oxidative stress induced by radiation. Other possible mechanism of action is that activation of NF-κB might play a pivotal role in the radioprotective effects of CpG-ODN in irradiated mice. 19) The link between NF-κB and the mammalian response to radiation had been established by previous reports showing that NF-κB is a critical factor in enhancing cell survival after radiation. Activation of NF-κB induced multiple factors that contribute to cell protection and promote tissue regeneration, including apoptosis inhibitors, reactive oxygen species scavengers, and cytokines. 3, 20) However, so far it is unclear which of these factors, which are also know to act synergistically, reduce the damage of hematopoiesis. It is conceivable that CpG-ODN targets immune cells and some bone marrow cells. A better understanding of the molecular, cellular and physiological mechanisms related to the effects of CpG-ODN on hematopoiesis in irradiated mice will require further studies.
